A U.S. government-funded task force for the first time recommended against the use of low-dose aspirin as a preventative measure against heart disease in adults over the age of 60.
The U.S. Preventative Services Task Force (USPTF) issued its draft recommendation on Oct. 12, stating that the use of the drug “has no net benefit” for the prevention of cardiovascular disease events in people 60 years or older.
